Quick Summary
• George Mason University and North Carolina company Phase Inc. have been awarded a National Science Foundation STTR grant to develop a new class of 3D printed microfluidic devices. The goal is to carry the technology out of the research lab and into wider use, yielding a more dependable route to the tools that organ-on-a-chip development…
Additional Context
George Mason University and North Carolina company Phase Inc. have been awarded a National Science Foundation STTR grant to develop a new class of 3D printed microfluidic devices. The goal is to carry the technology out of the research lab and into wider use, yielding a more dependable route to the tools that organ-on-a-chip development and human-centered biomedical research increasingly depend on.
The collaboration merges the extracellular vesicle (EV) biology work of College of Science professor Ramin M. Hakami’s group with the bioengineering and materials expertise of College of Engineering and Computing associate professor Remi Veneziano’s group, building on a microfluidic EV platform the two teams previously developed and published together. Phase brings its ambition to build a fully